The human pre-MRNA splicing factors SF2 and SC35 have similar dectrophoretic mobil , and both of them contain an N-terminal ribonucleoprotein (RNP)-type RNA-recognition motif and a C-terminal ginine/serine-rich domain. However, the two proteins are encoded by different genes and display only 31% amino acid sequence identity. Here we report a systematic comp of the splicing activities of recombinant SF2 and SC35. We find that either protein can reconsitute the splicing activity of S100 extracts and of SC35-immunodepleted nuclear extracts. Previous studies revealed that SF2 influences alternative 5' splice site in vilro, by favoring proximal over distl 5' splice sites, and that the Al protein of heterogeneous nuclear RNP counterats this effect. We now show that SC35 has a similar effect on compeig 5' spike sites a is also agonized by A prein. In adio, we report that both SF2 and SC35 also favor the proximal ste in a pre-mRNA coting duplIcated 3' splice sites, but this effect is not modulated by Al. We conclude that SF2 and SC35 are distnct splicn factors, but they display splicing activities in vitro.Nuclear pre-mRNA splicing takes place in spliceosomes, high molecular weight complexes containing small nuclear ribonucleoprotein (snRNP) particles and non-snRNP protein splicing factors (1). Our laboratories have identified and characterized two distinct non-snRNP splicing factors designated SF2 (splicing factor 2) (2-4) and SC35 (spliceosome component of 35 kDa) (5, 6). SF2 is also known as ASF or ASF-1 (alternative splicing factor) (7, 8), whereas SC35 has also been termed PR264 (9). In separate studies, SF2/ASF (3, 7) and SC35 (5, 10, 11) were shown to be required for the first step of splicing and for the assembly ofthe earliest detectable ATP-dependent prespliceosome complex (A complex). SF2 was originally identified by its ability to complement splicingdeficient HeLa cell S100 extracts (2), and SC35 by its ability to complement nuclear extracts immunodepleted with an anti-SC35 monoclonal antibody (mAb) raised against partially purified mammalian spliceosomes (5, 10 (8,14), whereas recombinant SC35 produced in a baculovirus system could complement anti-SC35 immunodepleted extracts (6). Recently, both proteins were shown to be members of the SR family of phosphoproteins (17-19). Proteins in this family are recognized by mAb 104, which is specific for a shared phospho-epitope; copurify in a highly selective two-step purification procedure; and contain an N-terminal RRM and a C-terminal RS domain (19). The SR family consists of at least five members of apparent molecular mass 20, 30, 40, 55, and 75 kDa, which are highly conserved between Drosophila and man. The 55-kDa polypeptide, SRp55 (17), isolated from a Drosophila cell line, can complement HeLa cell S100 extracts for splicing and causes the preferential selection of proximal 5' splice sites (18). Moreover, each of the 30-, 40-, 55-, and 70-kDa SRpolypeptides from calfthymus, recovered individually from SDS/polyacrylamide gels, can complement HeLa ce...